Technology
Greenberg Traurig Expands MedTech Practice with Addition of Christopher Bolten
Published
7 months agoon
By
Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences & Medical Technology Practice.
SAN DIEGO, May 29, 2024 /PRNewswire-PRWeb/ — Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences & Medical Technology Practice. He will be based in the firm’s San Diego office.
Trained as a mechanical engineer, Bolten’s practice focuses on medical technology (MedTech). He helps medical device and digital health companies across the United States, Europe, and Israel build patent portfolios to protect and enforce their intellectual property (IP). Bolten also provides IP due diligence services for venture capital firms and advises on associated risks related to their MedTech investments.
“Health care companies are now thinking more like technology companies, so Chris’s area of practice is an essential addition to our robust IP and Patents and Innovation Strategies practices,” said G. Michelle Ferreira, senior vice president of the firm and co-managing shareholder of the San Francisco and Silicon Valley offices. “He has a broad cross-border practice that runs the gamut from startups seeking FDA approval for single devices to well-established multinational public companies; in other words, Chris’s clients could benefit from Greenberg Traurig’s vast global platform.”
Bolten has been advising digital health companies using artificial intelligence and machine learning before “AI” became household terminology. Whether it was working with companies that used AI to assist surgical robots or to analyze heart signals to help diagnose cardiac abnormalities like atrial fibrillation – a feature now found in FDA-approved consumer smartwatches – Bolten has been at the forefront of AI’s overlap with digital health for many years, where the goal has always been to enhance patient care.
“I worked with Chris when he was a junior attorney, and it’s been a joy to see his rise here in Southern California, where he is well-known in the tech and legal spaces,” Shareholder David A. Gay, Ph.D. said. “Chris will perfectly complement the existing life sciences practice we have developed both in San Diego and across the firm.”
Bolten’s previous work with wireless communication and cellular technology has come full circle; he has seen his own practice areas of communications and medical devices converge. More digital health companies are creating software and collecting data with the goal of helping patients receive targeted diagnoses or medical treatment, often with the help of AI.
“Greenberg Traurig’s footprint and global platform overlap neatly with where my clients are based,” Bolten said. “The firm has a stellar reputation in the IP and patent prosecution community, and I could not be more excited to join a first-class group of attorneys.”
Bolten received his J.D. from the Arizona State University Sandra Day O’Connor College of Law, magna cum laude, and a B.S. in mechanical engineering, with honors, from Michigan State University. He is admitted to practice law in California and before the U.S. Patent and Trademark Office, as well as the Federal Circuit Court of Appeals and District Courts in California, Colorado, and Texas. Bolten joins the firm from Eversheds Sutherland.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.
Media Contact
Joey Kaiser, Greenberg Traurig, 2128016983, Joey.Kaiser@gtlaw.com, https://www.gtlaw.com/en
View original content:https://www.prweb.com/releases/greenberg-traurig-expands-medtech-practice-with-addition-of-christopher-bolten-302155319.html
SOURCE Greenberg Traurig
You may like
Technology
CLOU Electronics Earns Global Recognition in BloombergNEF’s 2024 Bankability Rankings
Published
52 minutes agoon
December 26, 2024By
DALLAS, Dec. 26, 2024 /PRNewswire/ — Bloomberg New Energy Finance (BNEF) has released its Storage Providers and Integrators Bankability List 2024, with CLOU Electronics achieving a notable improvement in its ranking compared to last year. Recognized by BNEF—a leading authority in the renewable energy sector—this distinction underscores CLOU’s comprehensive strength, market competitiveness, and ability to earn the trust of capital markets. This achievement further reflects the confidence of customers worldwide in CLOU’s technological innovation, product reliability, and brand value.
In Q4 2024, CLOU achieved another distinction by being simultaneously listed in the BNEF Energy Storage Tier 1 List Q4 2024 and the BNEF PCS and Inverter Tier 1 List Q4 2024. As one of the few companies excelling in both categories, CLOU continues to showcase its industry-leading product technology and innovation capabilities.
CLOU’s commitment to providing safe and reliable energy storage solutions is exemplified in its diverse product portfolio. For utility-scale applications, the Aqua-C 2.5 system integrates long battery modules into a compact 20-foot container, offering a nominal capacity exceeding 5MWh, high power density, exceptional stability across various environments, and low noise levels. For commercial and industrial (C&I) applications, CLOU’s Aqua-E series provides scalable solutions starting at 233kWh, with a 418kWh model already in development.
CLOU continues to deepen its presence in the Americas, expand into European markets, and accelerate its global reach into emerging regions such as Asia-Pacific and the Middle East. With subsidiaries in Dallas, Texas, and Germany, CLOU is strategically positioned to serve its growing international customer base.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clou-electronics-earns-global-recognition-in-bloombergnefs-2024-bankability-rankings-302339208.html
SOURCE CLOU Electronics Co., Ltd.
Technology
iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results
Published
52 minutes agoon
December 26, 2024By
BEIJING, Dec. 26, 2024 /PRNewswire/ — iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.
Third Quarter 2024 Highlights
Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.Average total MAUs[1] reached a record-high of 29.12 million, a year-over-year increase of 14.8%.
[1] “Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.
Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, “In the third quarter, we continued to see robust user demand for our products, driving average total MAUs to another record high of 29.12 million, representing a year-over-year increase of 14.8%. This growth underscores the effectiveness of our product strategy focused on innovation, overseas market expansion, and responsiveness to evolving market dynamics.
Domestically, we further strengthened our market leadership by enhancing our product portfolio with the launch of iHuman Chinese Reading. This new offering aims to cultivate an interest in Chinese reading, enhance literacy and verbal skills, and deepen children’s understanding of the Chinese culture. Developed by the same team behind our highly acclaimed iHuman Chinese app, iHuman Chinese Reading continues our proud tradition and commitment to excellent content and innovative design. The course features a leveled reading system that facilitates gradual progress in Chinese proficiency and offers a rich variety of content formats, such as ancient Chinese poems, interactive storybooks, and online study tours.
Building on our foundation, we expanded our content library by strengthening ties with influential industry players and leveraged our advanced technology to create richer and more immersive experiences for children. For instance, through our previously announced strategic partnership with Children’s Fun Publishing Co. Ltd., a leading children’s book publisher in China, we recently launched a new “Frozen” theme within iHuman Little Artists, where children can color their favorite Frozen characters and scenes, upload their artwork, and watch them come to life in a narrated storybook. This integration provides children with a creative way to experience the popular Frozen story while offering a highly interactive reading and drawing experience.
We also continued to roll out updates across other app products. For example, we added two new themes to iHuman Magic Thinking: “Sudoku” and “Thinking Logic.” “Sudoku” introduces children to Sudoku rules and mathematical concepts through short, animated stories and interactive challenges, and “Thinking Logic” engages them with a detective story series designed to sharpen judgment, analytical thinking, and problem-solving abilities.
On the international front, we enriched our portfolio with fresh content and features to boost user engagement and expand our global reach. Aha World received several updates, adding even more fun and adventure to its ever-expanding fantasy world. Children can now explore the “Love Animal Shelter,” where they can adopt, wash, and care for adorable virtual pets and enjoy an immersive and joyful pet ownership experience. For those captivated by the mystical, we introduced themes like “Magic School” and “Magic Street,” which take children on enchanting adventures and introduce magical shops filled with delightful surprises. These efforts have further boosted Aha World’s popularity. By the end of September, Aha World achieved over 502 million cumulative views across various social media platforms and attracted more than 1.4 million followers globally, reflecting its growing appeal among young users worldwide.
Looking ahead, we remain focused on enhancing our diverse portfolio across markets to better promote children’s holistic development while advancing our sustainable growth initiatives,” concluded Dr. Dai.
Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, “In the third quarter of 2024, we achieved our eleventh consecutive quarter of profitability, with net income reaching RMB25.1 million. This sustained financial strength enables us to continue expanding our impact across diverse channels and customer segments. For instance, our animation studio, Kunpeng, broadened its product lineup with the launch of a new animated series, “Rainbow Crew,” in October. The new series swiftly gained traction following its release, topping the charts for children’s shows on leading streaming platforms, including Tencent Video, iQIYI, and Youku.
Beyond consumer-facing products, we have also built a robust B2B model that currently supports nearly 10,000 kindergartens and institutions across China. Our tailored content resources and solutions empower these institutions with a comprehensive suite of diverse, ready-to-use products that effectively meet the developmental needs of young children, promoting the high-quality development of kindergartens and institutions. Recently, we have opened an experience center in Zhongshan, Guangdong Province, which combines education, entertainment, hands-on experience, and some unique features. Designed as a one-stop demonstration hub for institutional customers and vendors, the center is organized into six key areas—core content, specialty content, extended services, a multi-functional hall, indoor play spaces, and outdoor activity zones—showcasing our interactive products and innovative approach to supporting early childhood development in a kindergarten setting. This hands-on experience enables institutions to gain a deeper understanding of how our offerings can seamlessly integrate into their educational environments. Moving forward, we will leverage our solid financial foundation and innovative product ecosystem to deepen our impact in both the consumer and business segments, reinforcing our industry-leading position and creating value for our shareholders.”
Third Quarter 2024 Unaudited Financial Results
Revenues
Revenues were RMB239.4 million (US$34.1 million), a decrease of 8.4% from RMB261.5 million in the same period last year, primarily due to more conservative consumer spending.
Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user acquisition strategy and ongoing product innovation.
Cost of Revenues
Cost of revenues was RMB75.5 million (US$10.8 million), compared with RMB74.9 million in the same period last year.
Gross Profit and Gross Margin
Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year. Gross margin was 68.4%, compared with 71.4% in the same period last year. The slight decrease in gross margin was mainly due to our increased focus on the offline component in the integrated online-offline product strategy to enhance the attractiveness of the product.
Operating Expenses
Total operating expenses were RMB143.2 million (US$20.4 million), compared to RMB146.2 million in the same period last year.
Research and development expenses were RMB59.3 million (US$8.5 million), a decrease of 10.4% from RMB66.2 million in the same period last year, primarily due to savings in payroll related expenses.
Sales and marketing expenses were RMB60.9 million (US$8.7 million), an increase of 12.7% from RMB54.0 million in the same period last year, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.
General and administrative expenses were RMB23.0 million (US$3.3 million), a decrease of 11.8% from RMB26.1 million in the same period last year, primarily due to savings in payroll related expenses, share-based compensation expenses, as well as other administrative expenses.
Operating Income
Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.
Net Income
Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.
Basic and diluted net income per ADS were RMB0.48 (US$0.07) and RMB0.47 (US$0.07), respectively, compared with RMB0.98 and RMB0.95 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.
Deferred Revenue and Customer Advances
Deferred revenue and customer advances were RMB298.9 million (US$42.6 million) as of September 30, 2024, compared with RMB318.6 million as of December 31, 2023.
Cash, Cash Equivalents and Short-term Investments
Cash, cash equivalents and short-term investments were RMB1,168.6 million (US$166.5 million) as of September 30, 2024, compared with RMB1,213.8 million as of December 31, 2023.
Extension of Share Repurchase Program
Given its confidence in the Company’s business prospects, the board of directors (the “Board”) has authorized an extension of the Company’s existing share repurchase program, as authorized in December 2021 and extended to remain effective to the end of December 2024, by another twelve months through December 31, 2025. Pursuant to the extended share repurchase program, the Company’s proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 30, 2024, which was RMB7.0176 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman’s management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company’s current operating performance and prospects in the same manner as management does, if they so choose.
Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements. Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman’s unique, fun and interactive product offerings stimulate children’s natural curiosity and exploration. The Company’s comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children’s abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children’s behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.
For more information about iHuman, please visit https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares, ADSs, per share and per ADS data)
December 31,
September 30,
September 30,
2023
2024
2024
RMB
RMB
US$
ASSETS
Current assets
Cash and cash equivalents
1,213,767
651,684
92,864
Short-term investments
–
516,910
73,659
Accounts receivable, net
60,832
66,376
9,459
Inventories, net
16,518
16,882
2,406
Amounts due from related parties
1,810
2,099
299
Prepayments and other current assets
89,511
102,036
14,540
Total current assets
1,382,438
1,355,987
193,227
Non-current assets
Property and equipment, net
6,169
3,893
555
Intangible assets, net
23,245
21,121
3,010
Operating lease right-of-use assets
3,648
2,376
339
Long-term investment
26,333
26,333
3,752
Other non-current assets
8,662
10,937
1,556
Total non-current assets
68,057
64,660
9,212
Total assets
1,450,495
1,420,647
202,439
LIABILITIES
Current liabilities
Accounts payable
22,139
25,761
3,671
Deferred revenue and customer advances
318,587
298,896
42,592
Amounts due to related parties
4,428
20,719
2,952
Accrued expenses and other current liabilities
143,677
116,382
16,584
Dividend payable
–
30,139
4,295
Current operating lease liabilities
1,927
1,683
240
Total current liabilities
490,758
493,580
70,334
Non-current liabilities
Non-current operating lease liabilities
1,933
735
105
Total non-current liabilities
1,933
735
105
Total liabilities
492,691
494,315
70,439
SHAREHOLDERS’ EQUITY
Ordinary shares (par value of US$0.0001 per share,
700,000,000 Class A shares authorized as of
December 31, 2023 and September 30, 2024;
125,122,382 Class A shares issued and 119,704,787
outstanding as of December 31, 2023; 125,122,382
Class A shares issued and 117,107,067 outstanding as
of September 30, 2024; 200,000,000 Class B shares
authorized, 144,000,000 Class B ordinary shares
issued and outstanding as of December 31, 2023 and
September 30, 2024; 100,000,000 shares
(undesignated) authorized, nil shares (undesignated)
issued and outstanding as of December 31, 2023 and
September 30, 2024)
185
185
26
Additional paid-in capital
1,088,628
996,089
141,942
Treasury stock
(16,665)
(23,579)
(3,360)
Statutory reserves
8,164
8,164
1,163
Accumulated other comprehensive income
17,955
13,828
1,970
Accumulated deficit
(140,463)
(68,355)
(9,741)
Total shareholders’ equity
957,804
926,332
132,000
Total liabilities and shareholders’ equity
1,450,495
1,420,647
202,439
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares, ADSs, per share and per ADS data)
For the three months ended
For the nine months ended
September 30,
June 30,
September 30,
September 30,
September 30,
September 30,
September 30,
2023
2024
2024
2024
2023
2024
2024
RMB
RMB
RMB
US$
RMB
RMB
US$
Revenues
261,496
215,107
239,407
34,115
767,692
689,517
98,255
Cost of revenues
(74,871)
(63,372)
(75,541)
(10,765)
(224,667)
(205,805)
(29,327)
Gross profit
186,625
151,735
163,866
23,350
543,025
483,712
68,928
Operating expenses
Research and development expenses
(66,168)
(57,219)
(59,307)
(8,451)
(191,253)
(184,449)
(26,284)
Sales and marketing expenses
(53,994)
(51,263)
(60,863)
(8,673)
(134,993)
(167,121)
(23,815)
General and administrative expenses
(26,070)
(24,426)
(22,998)
(3,277)
(78,787)
(75,148)
(10,709)
Total operating expenses
(146,232)
(132,908)
(143,168)
(20,401)
(405,033)
(426,718)
(60,808)
Operating income
40,393
18,827
20,698
2,949
137,992
56,994
8,120
Other income, net
19,507
9,410
8,024
1,143
33,721
26,444
3,768
Income before income taxes
59,900
28,237
28,722
4,092
171,713
83,438
11,888
Income tax expenses
(7,984)
(3,574)
(3,579)
(510)
(24,077)
(11,330)
(1,615)
Net income
51,916
24,663
25,143
3,582
147,636
72,108
10,273
Net income per ADS:
– Basic
0.98
0.47
0.48
0.07
2.79
1.37
0.20
– Diluted
0.95
0.45
0.47
0.07
2.70
1.33
0.19
Weighted average number of ADSs:
– Basic
52,747,426
52,496,541
52,283,334
52,283,334
52,834,352
52,502,206
52,502,206
– Diluted
54,772,536
54,295,419
54,011,420
54,011,420
54,753,124
54,332,011
54,332,011
Total share-based compensation expenses included in:
Cost of revenues
67
26
22
3
235
88
13
Research and development expenses
1,160
348
225
32
2,940
1,030
147
Sales and marketing expenses
147
45
39
6
585
130
19
General and administrative expenses
1,105
392
329
47
3,557
1,022
146
iHuman Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares, ADSs, per share and per ADS data)
For the three months ended
For the nine months ended
September 30,
June 30,
September 30,
September 30,
September 30,
September 30,
September 30,
2023
2024
2024
2024
2023
2024
2024
RMB
RMB
RMB
US$
RMB
RMB
US$
Operating income
40,393
18,827
20,698
2,949
137,992
56,994
8,120
Share-based compensation expenses
2,479
811
615
88
7,317
2,270
325
Adjusted operating income
42,872
19,638
21,313
3,037
145,309
59,264
8,445
Net income
51,916
24,663
25,143
3,582
147,636
72,108
10,273
Share-based compensation expenses
2,479
811
615
88
7,317
2,270
325
Adjusted net income
54,395
25,474
25,758
3,670
154,953
74,378
10,598
Diluted net income per ADS
0.95
0.45
0.47
0.07
2.70
1.33
0.19
Impact of non-GAAP adjustments
0.04
0.02
0.01
0.00
0.13
0.04
0.01
Adjusted diluted net income per ADS
0.99
0.47
0.48
0.07
2.83
1.37
0.20
Weighted average number of ADSs – diluted
54,772,536
54,295,419
54,011,420
54,011,420
54,753,124
54,332,011
54,332,011
Weighted average number of ADSs – adjusted
54,772,536
54,295,419
54,011,420
54,011,420
54,753,124
54,332,011
54,332,011
View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-third-quarter-2024-unaudited-financial-results-302339217.html
SOURCE iHuman Inc.
Technology
Smartee Expands Middle East Presence, Showcases Innovative Clear Aligner Solutions at Riyadh Conferences
Published
2 hours agoon
December 26, 2024By
RIYADH, Saudi Arabia, Dec. 26, 2024 /PRNewswire/ — Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, further strengthened its presence in the Middle East by unveiling its groundbreaking Clear Mandibular Repositioning Technology at three major orthodontic events in Riyadh: the 18th Saudi Orthodontic Society Annual Conference, the 15th World Implant Orthodontic Conference, and the 4th Saudi Orthodontic Clear Aligner Meeting. These events, held from December 12-14, 2024, brought together leading dental professionals from across the globe to explore advancements in orthodontic care.
Driving Innovation in a Growing Market
With a rising demand for clear aligners in emerging markets, especially the Middle East, Smartee is positioning itself at the forefront of this growth. Social media platforms like Instagram and TikTok are fueling the popularity of clear aligners by educating patients, while demand in Saudi Arabia, one of the region’s largest markets, continues to rise.
“As China-Saudi Arabia collaboration deepens, Chinese brands like Huawei, Xiaomi, and DJI have built strong reputations for quality and innovation in the Saudi market,” said Garie Zhou, Director of the International Business and Development Division at Smartee. “Smartee entered the Middle East in 2021, achieving regulatory certifications and providing localized training to address the unique needs of this region. By aligning with these market trends, we’re empowering orthodontic professionals to deliver superior care to their patients.”
Revolutionizing Complex Orthodontic Cases
At the event, Prof. Gang Shen, Smartee’s Chief Scientist in R&D, delivered a presentation on Smartee Clear Mandibular Repositioning Therapy— a novel approach aiming to address severe Class II jaw discrepancies. Prof. Gang Shen discussed the increasing need for personalized treatment in complex orthodontics cases, emphasizing that one-size-fits-all solutions are no longer sufficient in today’s clinical environment.
“As patient expectations evolve, so must orthodontic technology,” stated Prof. Gang Shen. “Modern patients demand personalized treatments, especially for complex cases. Clear Mandibular Repositioning Therapy equips orthodontists with the tools to address this demand and enhance trust in the treatment process. I invite my colleagues to explore this technology, which fosters open communication and improves patient outcomes.”
Commitment to Collaboration and Growth
Smartee’s participation in the Riyadh conference underscores its commitment to innovation, collaboration, and the global advancement of orthodontic care. Its strategic initiatives in the Middle East reflect Smartee’s dedication to providing world-class solutions and driving the evolution of orthodontic treatments.
For more information about Smartee and its clear aligner solutions, visit www.smarteealigners.com.
About Smartee Denti-Technology
Smartee Denti-Technology is a global leader in clear aligners and digital orthodontic solutions, committed to transforming smiles with innovative technologies. With a focus on patient-centric care, Smartee provides orthodontists worldwide with advanced tools and training to deliver personalized treatments.
Photo – https://mma.prnewswire.com/media/2587581/image_1.jpg
Photo – https://mma.prnewswire.com/media/2587582/image_2.jpg
Photo – https://mma.prnewswire.com/media/2587583/3.jpg
View original content:https://www.prnewswire.co.uk/news-releases/smartee-expands-middle-east-presence-showcases-innovative-clear-aligner-solutions-at-riyadh-conferences-302339199.html
CLOU Electronics Earns Global Recognition in BloombergNEF’s 2024 Bankability Rankings
iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results
Hong Kong stablecoins bill advances to the Legislative Council
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days ago
Wrap Up the Holidays with Bedsure Exceptional Discounts
-
Coin Market5 days ago
Fake crypto liquidity pools: How to spot and avoid them
-
Coin Market5 days ago
Relationship building is a hedge against debanking — OKX exec
-
Technology5 days ago
ICEYE expands its Earth Observation capabilities with launch of two SAR satellites for mid-inclination orbit on the Bandwagon-2 mission with SpaceX
-
Coin Market5 days ago
Ethereum NFT collections drive weekly volume to $304M
-
Technology5 days ago
The Art of Lightness: ASUS to Unveil World’s Lightest Copilot+ PC
-
Coin Market5 days ago
Spacecoin XYZ launches first satellite in outer space blockchain network
-
Technology5 days ago
SCANable Strengthens Existing West Coast Presence with Additional Cutting-Edge Mobile 3D and 4D Scanning Services